OptioSurgical Raises $3.3 Million To Expand Product Portfolio and Fuel Continued Growth

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

DENVER, July 25, 2019 /PRNewswire/ — OptioSurgical, Inc., an analytics software company that helps hospitals and surgery centers reduce medical device costs is pleased to announce the close of a $3.3 million funding round led by Next Frontier Capital. The company plans to allocate this capital towards continued growth of the OptioSurgical platform and expand into other specialties such as spine and cardiovascular.

“The current healthcare reimbursement landscape necessitates easy-to-use solutions that provides actionable ways for providers to reduce costs,” said Ryan Mughal, Co-Founder and CEO of OptioSurgical. “This investment supports our company’s mission to create a more sustainable healthcare system and continue to be a leader in medical device tracking and analytics.”

Founded in 2017, OptioSurgical’s software empowers supply chain and clinicians with key insights to make more intelligent decisions. The platform analyzes devices used, ranks surgeons by procedure, alerts on over-charging or mistaken charges, and automatically predicts savings opportunities. The software is able to take a 9-month RFP process down to a few days. The company is currently focused on the $50 billion orthopedic device market. On average, the company is able to reduce hospital and surgery center surgical costs by 20-40%.

“As a surgeon, I am tasked with providing high quality, cost effective outcomes for my patients. I am more than willing to change behavior, but it is very challenging for physicians to access cost information in an accurate and actionable way,” said Dr. Dave Laverty, Orthopedic Surgeon.

Rob McCarville, Principal at Medical Consulting Group, which develops and manages 70 surgery centers across the country, says, “Prior to OptioSurgical it was very difficult to access case cost information in real-time and engage surgeons on how to be more cost effective. With this software we are able to easily have those conversations and drive down costs.”

OptioSurgical will continue to expand its product offering in 2019 to serve ambulatory surgery centers and hospitals.

For more information about OptioSurgical, Inc., visit optiosurgical.com  

About OptioSurgical, Inc.

OptioSurgical is a software and analytics company that tracks medical devices used in surgery and helps providers reduce cost. It does this by leveraging a proprietary software platform with implant constructs across various surgical specialties. The software tracks devices in real-time and automatically populates savings opportunities, mistaken charges, and surgeon cost trends. OptioSurgical customers often see return on investment in the first 90 days. 

Press Contact:

info@optiosurgical.com
(844) 809-7400

View original content:http://www.prnewswire.com/news-releases/optiosurgical-raises-3-3-million-to-expand-product-portfolio-and-fuel-continued-growth-300891232.html

SOURCE OptioSurgical

Staff

Recent Posts

Solventum partners with SprintRay to disrupt the digital dentistry market with high-quality, permanent same-day restorations

In this first-of-its-kind partnership for its Dental Solutions business, Solventum, formerly 3M Health Care, is…

2 hours ago

Health in Tech Expands Access to Virtual Care Through Collaboration with DialCare

STUART, Fla., March 25, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform…

8 hours ago

Concord Orthopaedic Notifies Individuals of Security Incident

CONCORD, N.H., March 25, 2025 /PRNewswire/ -- Concord Orthopaedic ("COPA") is an orthopedic clinic located…

8 hours ago

Mitolyn Brand Takes Legal Action Against Third-Party Sellers for Misinformation

HAMPTON, Va., March 25, 2025 /PRNewswire/ -- Bioventra, the parent company and official manufacturer of Mitolyn,…

8 hours ago

THE MOM’S CHOICE AWARDS NAMES AI-POWERED PREGNANCY & BABY WELLNESS WEARABLE ‘ELORA’ AMONG THE BEST IN FAMILY-FRIENDLY PRODUCTS

DOVER, Del., March 25, 2025 /PRNewswire/ -- The Mom's Choice Awards® has named Elora*, from leading…

8 hours ago

Paving the Way for Early Esophageal Cancer Detection:

New Sampling Technique Further Optimizes WATS3D Test Quality SUFFERN, N.Y., March 25, 2025 /PRNewswire/ -- CDx…

8 hours ago